ADVFN Logo
Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

CRL Charles River Laboratories International Inc

230.09
-2.25 (-0.97%)
Apr 17 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 499,836
Bid Price
Ask Price
News -
Day High 234.40

Low
161.65

52 Week Range

High
275.00

Day Low 229.85
Company Name Stock Ticker Symbol Market Type
Charles River Laboratories International Inc CRL NYSE Common Stock
  Price Change Change Percent Stock Price Last Traded
-2.25 -0.97% 230.09 20:00:00
Open Price Low Price High Price Close Price Prev Close
234.40 229.85 234.40 230.09 232.34
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
12,243 499,836 $ 231.00 $ 115,463,066 - 161.65 - 275.00
Last Trade Time Type Quantity Stock Price Currency
19:00:00 77,967 $ 230.09 USD

Charles River Laboratories International Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
11.81B 51.35M - 4.13B 474.62M 9.24 24.87
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Charles River Laboratories News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No CRL Message Board. Create One! See More Posts on CRL Message Board See More Message Board Posts

Historical CRL Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week249.23250.72229.85240.88396,626-19.14-7.68%
1 Month266.33274.765229.85257.32424,674-36.24-13.61%
3 Months216.05275.00211.23246.73529,17114.046.50%
6 Months190.79275.00161.65220.62543,79639.3020.60%
1 Year204.60275.00161.65211.38518,43925.4912.46%
3 Years321.95460.21161.65256.59518,059-91.86-28.53%
5 Years138.86460.2195.58232.48451,62991.2365.70%

Charles River Laboratories Description

Charles River Laboratories was founded in 1947 and is a leading provider of drug discovery and development services. The company's research model & services segment is the leading provider of animal models for laboratory testing, which breeds and delivers animal research models with specific genetic characteristics for preclinical studies around the world. The discovery & safety assessment segment includes services required to take a drug through the early development process, including discovery services. The manufacturing support segment includes microbial solutions, which provides in vitro (non-animal) testing products, biologics testing services, and avian vaccine services.

Your Recent History

Delayed Upgrade Clock